巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    111, Inc

    YI
    2.420
    0.260
    9.70%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・111, Inc - 延遲價格・最後更新於 05/08 9:30
    最高位
    2.590
    最低位
    2.420
    開市價
    --
    前收市價
    2.680
    成交量(千)
    1.86
    成交額(百萬)
    0.04
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    201.52
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    8.250 - 1.370
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    111, Inc
    證券代碼
    YI.US
    所屬板塊
    Pharmaceutical Retailers
    公司業務
    111 Inc is engaged in online retail and wholesale pharmacy. It operates an integrated online and offline platform in the healthcare ecosystem in China. It is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in China. It manages operations into two segments: the B2C segment and the B2B segment. The B2B segment generates the vast majority of its revenue.
    發行量
    83271583
    公司總部
    No.295 ZuChongZhi Road, 3-5 Floors, Pudong New Area
    公司網址
    http://ir.111.com.cn
    公司電郵
    ir@111.com.cn
    公司電話
    +86 2120536666

    長實售新加坡36個商舖予置富 作價為5億元

    張偉倫·
    長實售新加坡36個商舖予置富 作價為5億元

    港股全日升27點 阿里巴巴績後跌逾2% 半導體股向好

    翟梓謙·
    港股全日升27點 阿里巴巴績後跌逾2% 半導體股向好

    長實中期多賺55% 派息43仙 李澤鉅﹕展現嚴謹財務紀律抵風浪

    張偉倫·
    長實中期多賺55% 派息43仙 李澤鉅﹕展現嚴謹財務紀律抵風浪

    港股企穩2萬點 全日彈升406點 惟交投淡靜成交額不足900億元

    張偉倫·
    港股企穩2萬點 全日彈升406點 惟交投淡靜成交額不足900億元

    港股反彈 晶片及科技股獲追捧 中芯勁升逾4%

    張偉倫·
    港股反彈 晶片及科技股獲追捧 中芯勁升逾4%

    關於

    111, Inc(YI.US)所屬的行業板塊為Pharmaceutical Retailers。
    111 Inc is engaged in online retail and wholesale pharmacy. It operates an integrated online and offline platform in the healthcare ecosystem in China. It is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in China. It manages operations into two segments: the B2C segment and the B2B segment. The B2B segment generates the vast majority of its revenue.
    詳細公司背景可參考: http://ir.111.com.cn